Loading...
01/11 03:07
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong growth in Asia, particularly in individual protection sales and total CSM, which are significant positive indicators. The Q&A section reveals some challenges, such as Medicaid repricing and stop-loss business pricing, but overall, the company maintains a strong capital position with ongoing share buybacks and positive asset management performance. The company's focus on digital transformation and capital management further supports a positive outlook. Despite some uncertainties, the overall sentiment leans towards a positive market reaction, especially with optimistic guidance in key growth areas.
Underlying EPS $1.86, up 6% year-over-year. This increase reflects the benefits and strength of Sun Life's diversified business model.
Underlying ROE 18.3%, progressing well towards medium-term objectives. This reflects higher earnings and the impact of share buybacks.
Book Value Per Share Grew 3% quarter-over-quarter. This growth demonstrates the company's ability to generate strong growth while returning value to shareholders.
Individual Protection Sales Grew 35% year-over-year. This growth was driven by strong demand for participating life policies sold through both third-party and proprietary channels.
Group - Health & Protection Sales Grew 12% year-over-year. This growth reflects business expansion and favorable insurance experience in Canada.
Net Flows in Asset Management and Wealth Almost $3 billion of positive net flows. This reflects steady growth in asset management net flows, including strong capital raising and deployments.
Underlying Net Income $1.047 billion, up 3% year-over-year. This increase reflects strong growth in Asia and Canada, partially offset by lower earnings in the U.S.
Asset Management and Wealth Underlying Earnings Up 5% year-over-year. This growth was driven by improved credit, higher fee income in Canada, and higher net seed investment income at SLC Management.
Group - Health & Protection Underlying Earnings Down 18% year-over-year. This decline was driven by unfavorable insurance experience across the U.S., partially offset by business growth and favorable insurance experience in Canada.
Individual Protection Underlying Net Income Up 25% year-over-year. This growth was driven by business growth, favorable mortality experience in Asia, joint venture earnings in India, and higher investment earnings in Canada.
Total CSM Increased 12% year-over-year to $14.4 billion. This growth was driven by strong organic CSM growth.
New Business CSM $446 million, increased 16% year-over-year. This growth was driven by strong sales compared to the same period last year.
Organic Capital Generation $624 million, 60% of underlying net income, well above the target range of 30% to 40%. This reflects strong organic capital generation net of dividends.
LICAT Ratio 154%, up 3 points from the prior quarter. This increase was driven by a $1 billion debt issuance and organic capital generation, partially offset by share buybacks.
Holdco Cash $2.1 billion. This reflects a strong capital position.
Leverage Ratio 21.6%, remains low. This reflects disciplined financial management.
MFS Underlying Net Income USD 215 million, down 1% year-over-year. This decline was primarily due to a decrease in net interest income, mostly offset by higher fee income on average net asset growth.
MFS Pretax Operating Margin 39.2%, decreased 1.3 percentage points year-over-year. This decline was primarily due to lower interest income.
MFS Assets Under Management (AUM) USD 659 billion, up 2% year-over-year and up 4% quarter-over-quarter. This growth was driven by market appreciation, partially offset by net outflows.
SLC Management Underlying Net Income $54 million, up 15% year-over-year. This growth was driven by higher net seed investment income and higher fee-related earnings.
SLC Fee-Earning AUM $199 billion, up 9% year-over-year. This growth was driven by net flows, partially offset by realizations.
Canada Reported Net Income $422 million, up 13% year-over-year. This growth was driven by strong business growth, favorable insurance experience, and higher fee income.
Canada Asset Management and Wealth Underlying Earnings Up 19% year-over-year. This growth was driven by improved credit experience and higher fee income from AUM growth.
Canada Group - Health & Protection Earnings Up 15% year-over-year. This growth reflects business growth, favorable mortality and morbidity experience, and improved credit.
Canada Individual Protection Sales Up 16% year-over-year. This growth was driven by solid demand for nonparticipating life products across both third-party and proprietary sales channels.
U.S. Underlying Net Income USD 107 million, down 34% year-over-year. This decline was driven by unfavorable insurance experience in medical stop-loss, higher claims frequency in Dental, and unfavorable disability experience in Employee Benefits.
U.S. Group - Health & Protection Sales USD 273 million, up 25% year-over-year. This growth was driven by higher large case sales in Employee Benefits and higher government sales in Dental.
Asia Underlying Net Income $226 million, up 32% year-over-year. This growth was driven by strong continued sales momentum, favorable mortality experience, and higher earnings in India.
Asia Individual Protection Sales Up 38% year-over-year. This growth was driven by double-digit sales growth across most markets and channels.
Asia Total CSM $6.5 billion, grew 17% year-over-year. This growth was driven by strong organic CSM growth.
Asia New Business CSM $322 million, up 20% year-over-year. This growth was driven by strong sales.
Individual Protection Sales: Grew 35% year-over-year, driven by strong demand for participating life policies in Canada and double-digit growth in six Asian markets.
Group Health & Protection Sales: Increased by 12%, with notable growth in U.S. Employee Benefits and Dental segments.
Asset Management and Wealth: Achieved almost $3 billion in positive net flows, with strong capital raising and deployments at SLC Management and institutional net inflows at MFS.
New ETF Series in Canada: Launched by Sun Life Global Investment, leveraging expertise from MFS, SLC, and Crescent Capital.
Asia Market Expansion: Double-digit growth in protection sales across six markets, with new business CSM growing 20% year-over-year.
India Asset Management JV: Manages $65 billion in assets, contributing to growth in Asia.
Canada Wealth Management: SLGI marked its 15th anniversary, growing to over $44 billion in AUM and becoming the largest Canadian-based provider of target-date funds for group retirement plans.
U.S. Business Challenges: Faced unfavorable insurance experience in group and dental segments due to structural changes in the U.S. healthcare system, but measures like repricing and expense actions are underway.
Capital Position: LICAT ratio of 154%, supported by $1 billion debt issuance and organic capital generation.
Shareholder Returns: Repurchased $400 million in shares and increased dividend by $0.04 to $0.92 per share.
Asset Management Leadership: Tom Murphy appointed as President of Sun Life Asset Management, effective January 1, 2026, to drive global growth.
Focus on Synergies: Plans to unlock synergies between asset management, insurance, and wealth businesses to accelerate growth.
U.S. Business Performance: The U.S. business underperformed expectations due to unfavorable insurance experience in group and dental segments. Structural changes in the U.S. healthcare system are driving higher claims frequency and costs. Additionally, the medical stop-loss business experienced a higher frequency of claims over $1 million, leading to increased stop-loss ratio assumptions.
Dental Business Challenges: The dental segment faces industry-wide headwinds from slower Medicaid contract repricing and higher claims frequency. Seasonal utilization spikes, particularly among children, further exacerbate the challenges.
Medical Stop-Loss Business: The medical stop-loss business is experiencing pricing shortfalls and elevated claims volumes, particularly from pre-2025 business and January 2025 blocks. This has necessitated adjustments to loss ratio assumptions.
Regulatory and Market Risks in U.S. Healthcare: Structural changes in the U.S. healthcare system are creating challenges, including higher claims costs and frequency, which impact the group benefits and dental businesses.
Asset Management Net Outflows: MFS experienced net outflows of $871 million, reflecting continued investor preference for risk-free investments. Retail outflows were significant, although institutional inflows partially offset this.
Asia Asset Management Growth Dependency: Growth in Asia's asset management business is heavily dependent on adding further capabilities and unlocking synergies with insurance and wealth businesses, which could pose execution risks.
U.S. Business Repricing and Growth: The U.S. Group Benefits and dental businesses are repriceable over a 1- to 3-year time frame. The company is focused on repricing, expense actions, and growth of its commercial business to improve U.S. dental business performance. The company is aligning its U.S. business for growth in the new realities of the U.S. health space.
Asia Growth Projections: Double-digit protection sales growth was achieved in six markets, with new business CSM growing 20% year-over-year. The company sees long-term growth potential in Asia asset management and plans to add further capabilities in Asia to support growth in asset management and investment returns in insurance and wealth businesses.
Asset Management Growth: The company is focused on accelerating the growth of its asset management businesses globally. Fee-earning assets under management at SLC grew 9% year-over-year, and the company is on track to achieve its full-year underlying earnings target of $235 million. MFS continues to deliver industry-leading pretax net operating margins with a 39.2% margin this quarter. The company sees significant interest in partnering with SLC from banks, insurers, reinsurers, and others.
Medium-Term Financial Objectives: The company is committed to achieving 10% underlying earnings growth, 20% ROE, and dividend payouts in the range of 40% to 50% of underlying earnings.
Capital Position and Shareholder Returns: The company ended the quarter with a LICAT ratio of 154%, demonstrating a strong capital position. It announced a $0.04 increase to its dividend to $0.92 per share and repurchased approximately $400 million of shares in the quarter.
Dividend Increase: Announced a $0.04 increase to the dividend, bringing it to $0.92 per share.
Dividend Payout Ratio: Committed to a dividend payout range of 40% to 50% of underlying earnings.
Share Buyback: Repurchased approximately $400 million of shares in the quarter.
Annual Share Repurchase: Over 19 million shares repurchased in the last 12 months, including 4.8 million shares this quarter.
The earnings call highlights strong growth in Asia, particularly in individual protection sales and total CSM, which are significant positive indicators. The Q&A section reveals some challenges, such as Medicaid repricing and stop-loss business pricing, but overall, the company maintains a strong capital position with ongoing share buybacks and positive asset management performance. The company's focus on digital transformation and capital management further supports a positive outlook. Despite some uncertainties, the overall sentiment leans towards a positive market reaction, especially with optimistic guidance in key growth areas.
The earnings call presents a mixed picture. While there are positive elements like the dividend increase, share buyback, and growth in Asia, concerns exist around Medicaid uncertainties, repricing delays, and loss of fees due to MPF changes. The Q&A reveals management's confidence in long-term growth but acknowledges near-term challenges. The neutral rating reflects the balance of positive strategic moves against the current operational uncertainties and financial impacts.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
